Home    Back

 87. Pulmonary veno-occlusive disease
 [ 3 clinical trials,    4 drugs（DrugBank: 3 drugs),    4 target genes / 44 target pathways ] 

Searched query = "Pulmonary veno occlusive disease", "Pulmonary capillary hemangiomatosis", "PVOD"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/21/2019, 11/20/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollement		Last_Refreshed_
on		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1JPRN-UMIN0000205432015/03/012 April 2019Efficacy of imatinib for the treatment of pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosispulmonary veno-occlusive disease/pulmonary capillary hemangiomatosisOral administration of imatinibNational Hospital Organization Okayama Medical CenterNot Recruiting18years-oldNot applicableMale and Female8Not applicableJapan
2NCT00891527October 200824 June 2019Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein StenosisAdjunct Targeted Biologic Inhibition in Children With Multivessel Intraluminal Pulmonary Vein StenosisPulmonary Veno Occlusive DiseaseDrug: Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)Boston Children’s HospitalNot recruitingN/AN/AAll50Phase 1/Phase 2United States
3NCT00563498July 200419 February 2015Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant RecipientsA Randomized Control Studies on the Effects of Glutamine on the Clinical Outcome of Bone Marrow Transplant Recipients With Special Reference to Veno-occlusive Disease and Mucositis.Pulmonary Veno-Occlusive Disease;Hepatic Veno-Occlusive Disease;MucositisDrug: GlutamineHospital Authority, Hong KongThe University of Hong Kong;Fresienius Kabi HK LtdRecruiting18 YearsN/ABoth40N/AChina